MyMeds&Me Reportum® solution deployed by Pfizer Inc. for Pharmacovigilance in the U.S. market

London, UK, 9 March, 2015: MyMeds&Me, a leading SaaS provider of web-based adverse event and product quality complaint capture solutions for life sciences, today announced the deployment of the Reportum® solution across all Pfizer safety call centre sites for the U.S. market. This marks the signing of a hosting agreement with Pfizer to adopt the Reportum® solution via Software as a Service (SaaS) delivery. Pfizer has deployed the Reportum® solution from MyMeds&Me as the standard for the U.S. Safety Call Centre, to support prompt availability of high quality safety data from reporters, including consumers, patients and healthcare professionals.

Supporting Quotes:

“Improving processes with an easy to use electronic solution is key to maintaining high levels of quality by reducing potential transcription errors and managing the calls in a structured way to obtain as much information as possible with the first contact.”, said Pfizer VP, Rob Goodwin. “Our selection of the Reportum® solution reflects our commitment to streamline our call handling processes with state of the art electronic solutions.”

“We are delighted to announce the SaaS deployment and successful roll-out of the Reportum® solution across Pfizer Safety Call Centre sites for the United States”, said Andrew Rut, CEO at MyMeds&Me. “We believe that Pfizer’s commitment to standardisation on this market-leading, innovative solution underlines the significance of the Reportum® solution to the pharmacovigilance market”.